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Doug Fine (2013) states in Too High to Fail: Cannabis and
the New Green Economic Revolution that to fully understand
marijuana prohibition and legalization, one needs to approach
it sociologically as well as scientiﬁcally. To gain a better
understanding of the subject, I conducted an extensive
literature review that included Fine (2013); Room, Fischer,
Hall, Lenton, and Reuter (2010), Cannabis Policy: Moving
Beyond Stalemate; Earleywine (2002), Understanding
Marijuana: A New Look at the Scientiﬁc Evidence; and Clark
and Merlin (2013), Cannabis: Evolution and Ethnobotany.
Historically, the cannabis plant has been used to support the
economy and heal the sick. However, in recent years it has been
used as a weapon to incarcerate and ﬁne millions of farmers,
caretakers, ill people, and recreational users (Fine, 2013; Room, et
al., 2010). Although the outlawed status of cannabis has stymied
its potential for experimentation, research on two of the plant’s
cannabinoids, tetrahydrocannabinol and cannabidiol, has shown
that they have potential use as medical treatments that greatly
improve the quality of life for humans and other mammals that
suffer from both chronic and acute conditions such as spasticity,
chronic nausea and vomiting, and chronic pain due to cancer (Clark
& Merlin, 2013; Earleywine, 2002). Because of this, cannabis and
cannabinoid scientists argue that cannabis should be declassiﬁed as
a Schedule I drug and legalized (Clark & Merlin, 2013).
Both marijuana activists and the Global Commission on Drug
Policy claim that legalization of cannabis would increase the
quality of life and decrease physical pain for millions of citizens,
as well as bring millions of dollars into the U.S. economy
(Fine, 2013). Cannabis has medical value beyond its isolated
cannabinoids, and the Global Commission on Drug Policy admits
that the war on drugs has failed (Clark & Merlin, 2013; Fine, 2013).
Law Enforcement Against Prohibition, a national activist group

consisting of former antidrug law enforcement agents who seek
to end marijuana prohibition, issued the following statement via
former ofﬁcer Chad Padgett: “Marijuana prohibition does not work
and never has. . . . We can prioritize violent crime . . . [or] we can
continue to prioritize a war on drugs which has not succeeded by
any measure” (Clark & Merlin, 2013).
Research advisor Harold Pinnick writes: “Whitney has generated
a thoughtful overview of the status of marijuana in the United
States. This includes not only the current status, but also the
historical background of this interesting topic. This work should
help stimulate future discussions about this important commodity.”
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Twenty-three states and the District of Columbia allow use of
marijuana for medical purposes. In 11 other states, lawmakers
have OK’d low THC, high cannabidiol (or CBD) products for
certain medical reasons.
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